6917 Vista Parkway N, Suite 14

West Palm Beach, FL 33411

Incubator: No

Founding Date:

E-Florida Region: Southeast

Ownership: Private


Cytonics is involved with the development of diagnostic assays and biopharmaceuticals, with a focus on orthopaedic and neurological clinical applications.


Therapeutics, Diagnostics


Cytokine technology; proteomics; diagnostic assays.

Research Focus

Therapeutics and diagnostics for radicular and joint pain; neurology; orthopedics; inflammation.

Products in Market

Cytonics has developed FACT, a diagnostic molecular biomarker used to identify symptomatic intervertebral discs or painful joint abnormalities. FACT is used to measure the presence of the Fibronectin-Aggrecan Complex (FAC) and other related biomarkers in a fluid specimen taken from patients with musculoskeletal pain. The company has also developed the Cytonics Autologous Platelet Integrated Concentration (“APIC”) System, which is indicated for the rapid preparation of autologous platelet rich plasma from a small sample of blood at the patient’s point of care. The platelet rich plasma is mixed with autograft and/or allograft bone prior to application to a bony defect for improving bone graft handling characteristics.

Recent Funding Source


The University of Florida and any third party content providers shall retain all worldwide rights in the intellectual property of this site including the copyright in and to its original content. You may reproduce the site content for any legal purpose with proper attribution. Attribution shall take the following form: "Materials provided by University of Florida's Sid Martin Biotechnology Incubator".